U.S. VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

1. Research Objective and Assumption

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By End User
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Epidemiology
   • Merger, Acquisition, and Collaboration
   • Regulatory Scenario
   • PEST Analysis

4. U.S. Vaccine Market, By Product Type, 2021–2033 (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Human Vaccine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
       • Pediatric Vaccines
       •  Adult & Adolescent Vaccines
       • Other Human Vaccines
   • Animal Vaccine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
       • Livestock Vaccines
       • Companion Animal Vaccines
       • Other Animal Vaccines

5. U.S. Vaccine Market, By End User, 2021–2033 (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Vaccination  Centers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends

6. Competitive Landscape

   • Company Profiles
     • Sanofi Pasteur *
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • GlaxoSmithKline Plc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Merck & Company Incorporated
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Pfizer Incorporated
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • AstraZeneca plc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Boehringer Ingelheim
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Bharat Biotech.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • BIO-MED
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Serum Institute of India Pvt. Ltd.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Kedrion Biopharma Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • GlaxoSmithKline plc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     •  Bilthoven Biologicals
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Cadila Healthcare Limited
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Sanofi Pasteur India Pvt Ltd
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Chiron Behring Vaccines Private Ltd
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Zoetis Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Elanco.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Boehringer Ingelheim International GmbH
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Indian Immunologicals Ltd
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Wyeth pharmaceuticals
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Berna Biotech Ltd.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Novartis Vaccines Ltd
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     •  Medimmune LLC.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies

7. Section

   • References
   • Research Methodology
   • About us and Sales Contact

*Browse 34 market data tables and 26 figures in “U.S. Vaccine Market–  Forecast to 2033